The report confirms the concerns about unintentional exposure to antineoplastic drugs and highlights several guidance notes that are generally available on this subject. Guidance began to appear in 1981. Medical consequences of exposure include the possibility of those with long latency periods e.g. heart disease. Occupational exposures would tend to be more complex than those of patients and, last much longer.
Evidence from:
TH Connor et al. CA Cancer J Clin (2006) Vol.56 p 354–365
“Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings”
Unlike patients, health care workers may be exposed at a low level for many years.
Further detail: